Rallybio Corporation (RLYB)
NASDAQ: RLYB · Real-Time Price · USD
0.2694
-0.0008 (-0.30%)
Apr 15, 2025, 9:54 AM EDT - Market open

Rallybio Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019
Net Income
-57.78-74.56-66.65-47.01-26.45
Upgrade
Depreciation & Amortization
0.130.150.170.110.06
Upgrade
Loss (Gain) From Sale of Investments
-1.61-3.09-0.44--
Upgrade
Loss (Gain) on Equity Investments
2.242.041.081.511.52
Upgrade
Stock-Based Compensation
7.9910.929.53.650.7
Upgrade
Change in Accounts Payable
-0.7-0.10.49-0.980.72
Upgrade
Change in Unearned Revenue
1.06----
Upgrade
Change in Other Net Operating Assets
-0.624.38-1.42-2.81.4
Upgrade
Operating Cash Flow
-49.28-60.27-57.28-45.53-22.04
Upgrade
Capital Expenditures
--0.01-0.05-0.33-0.14
Upgrade
Investment in Securities
33.4927.67-112.12-2-1.94
Upgrade
Investing Cash Flow
33.4927.66-112.17-2.33-2.07
Upgrade
Issuance of Common Stock
5.470.2851.7786.2145.21
Upgrade
Other Financing Activities
-0.27-0.14-0.69-3.23-0.32
Upgrade
Financing Cash Flow
5.20.1451.0882.97144.89
Upgrade
Net Cash Flow
-10.59-32.46-118.3835.1120.78
Upgrade
Free Cash Flow
-49.28-60.28-57.34-45.87-22.18
Upgrade
Free Cash Flow Margin
-7748.74%----
Upgrade
Free Cash Flow Per Share
-1.13-1.49-1.80-1.80-1.27
Upgrade
Levered Free Cash Flow
-28.05-34.15-33.77-28.91-12.75
Upgrade
Unlevered Free Cash Flow
-28.05-34.15-33.77-28.91-12.71
Upgrade
Change in Net Working Capital
0.43-4.120.963.8-2.47
Upgrade
Updated Mar 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q